Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Ping An Biomedical (PASW) Shares Outstanding (2024 - 2025)

Ping An Biomedical filings provide 2 years of Shares Outstanding readings, the most recent being $2.9 million for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 14.04% to $2.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.9 million, a 14.04% increase, with the full-year FY2025 number at $2.8 million, up 13.22% from a year prior.
  • Shares Outstanding hit $2.9 million in Q3 2025 for Ping An Biomedical, up from $2.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $2.9 million in Q3 2025 to a low of $2.5 million in Q3 2024.